Roy Twight
CEO
Replay available
IMI plc (LSE: IMI) Q1 2026 earnings conference call, held 2026-05-12. Replay captured from the company's public earnings webcast.

CEO
CFO
Analyst, JP Morgan
Analyst, Goldman Sachs
Analyst, B&B Paribas
Analyst, Barclays
Analyst, Alpha Value
Analyst, Bloomberg Intelligence
Good morning, everyone, and thank you for joining us on today's IMI PLC Q1 Trading Update. My name's Drew and I'll be the operator on the call today. After the prepared remarks, we will have a Q&A session. If you would like to register for a question during that time, please press star followed by one on your telephone keypad and to withdraw your question if star followed by two. With that, it's my pleasure to hand over to Roy Twight, CEO to begin. Please go ahead when you're ready. Good morning, everybody, and welcome to IMI's first quarter training update. I'm joined here today by our CFO, Luke Grant. We have made a good start to the year, delivering organic growth across IMI in the first quarter. This performance reflects the strength of the one IMI operating model, our strategic focus on three mega trends, energy, automation, and healthcare, and the continued efforts from all of our people globally. We are pleased to reconfirm our full-year guidance, remain firmly on track to deliver our sixth consecutive year of mid-single-digit organic revenue growth in 2026, and we continue to expect that full year adjusted EPS will be between 136 pence and 142 pence. Process automation delivered strong revenue growth. As expected, order intake was slightly lower year on year against a strong Q1 comparator, particularly in the aftermarket, where we grew 19% organically in the first quarter of last year, driven by several large nuclear orders that we previously announced. Industrial automation performed in line with expectations, benefiting from an easier comparator following the cyber incident in the first quarter of last year. Climate control continues to perform well, supported by demand for our energy-efficient solutions. Life sciences and fluid control was slightly better ...